About P&T JournalContacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
Vice President, Group Publisher
Production: Mary Ellen Curry,
Director of Production Services
Circulation: Jackie Ott, Circulation Manager
Statement of Purpose
Guidelines for Authors
Letter to the Editor
The Patient Safety and Quality Improvement Act (H.R.663) encourages providers to conduct research and gather data about the causes of medical mishaps and then share their findings with other providers.
The author reviews adalimumab for rheumatoid arthritis, alefacept for
psoriasis, and cyclosporine ophthalmic emulsion for chronic dry eye disease.
Marvin M. Goldenberg, PhD, RPh, MS
A practicing physician describes the fears that surgeons must confront when
treating high-risk patients.
Thomas Marzili, MD
Continuing Education Credit
The author reviews a new medication for the treatment of invasive aspergillosis, febrile neutropenia, and candidiasis.
S. Scott Sutton, PharmD
Editor-in-Chief David Nash, MD, MBA, highlights a company that helps employees resolve problems with their health benefits.
David B. Nash, MD, MBA
Dr. Nancy Greengold is the newest addition to P&T’s Editorial Board.
Matthew Grissinger discusses the “rule of 6” shortcut and its tendency to lead to errors.
Stephen Barlas describes the confusion surrounding President Bush’s proposed Medicare drug benefit.
The latest information about approvals, indication changes, industry updates, and news from the FDA
Dr. Vanni and Mr. Inzerillo review aripiprazole, a new antipsychotic medication.
Nicholas Vanni, PharmD, and Michael T. Inzerillo, MBA